Join
Live feed
·
PRReleasevia Quantisnow
Fusion Pharmaceuticals Inc. logo

Fusion Pharmaceuticals Appoints Industry Veteran Christopher Leamon, Ph.D., as Chief Scientific Officer

ByQuantisnow·Wall Street's wire, on your screen.
FUSN· Fusion Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FUSN (Fusion Pharmaceuticals Inc.) and more on Quantisnow.